全球糖化血紅素（HbA1c）檢測市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

HbA1c 檢測市場預計將從 2025 年的 24.9 億美元成長到 2034 年的 70.2 億美元，2026 年至 2034 年的複合年成長率為 12.2%。

由於糖尿病盛行率不斷上升以及人們對預防性護理的日益重視，HbA1c檢測市場預計將迎來顯著成長。隨著醫療機構致力於糖尿病的早期診斷和管理，HbA1c檢測已成為監測長期血糖控制的重要工具。此檢測不僅有助於診斷糖尿病，而且在評估治療方案的有效性方面也發揮關鍵作用，使其成為糖尿病護理的重要組成部分。

診斷檢測技術的進步正在改變糖化血紅蛋白（HbA1c）檢測的模式。就地檢驗設備的創新提高了檢測的可及性和便利性，使患者能夠更有效地管理血糖值。這些設備能夠快速提供檢測結果，從而實現及時介入和個人化治療方案。此外，行動應用程式和遠端醫療等數位健康解決方案的整合提高了患者的參與度和治療通訊協定的依從性，最終改善了整體健康狀況。

人們對糖尿病管理重要性的認知不斷提高，也推動了市場擴張。公共衛生措施旨在教育大眾了解糖尿病控制不佳的風險，促使更多人尋求定期檢測。隨著醫療保健系統日益重視以價值為導向的醫療服務，對可靠、準確的糖化血紅蛋白（HbA1c）檢測解決方案的需求預計將進一步成長。在這種不斷變化的環境中，相關人員已做好充分準備，掌握HbA1c檢測市場的成長潛力，推動創新，並在此過程中改善患者照護。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球糖化血紅素檢測市場（依產品類型分類）

• 市場分析、洞察與預測
• 裝置
• 試劑
• 成套工具

5. 全球糖化血紅素 (HbA1c) 檢測市場（依技術分類）

• 市場分析、洞察與預測
• 離子交換高效液相層析法
• 酵素法
• 親和性和結合層析法
• 濁度免疫抑制檢測法
• 其他

6. 全球糖化血紅素檢測市場（依最終用戶分類）

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 居家照護
• 研究所
• 其他

7. 全球糖化血紅素檢測市場（按地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Bio-Rad LaboratoriesInc
  • ARKRAYInc
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • TransAsia Bio-Medicals
  • Trinity Biotech Ireland
  • EKF Diagnostics
  • Randox Laboratories Ltd
  • HemoCue India
  • Eurolyser Diagnostica GmbH
  • Sekisui Diagnostics

The HbA1c Testing Market size is expected to reach USD 7.02 Billion in 2034 from USD 2.49 Billion (2025) growing at a CAGR of 12.2% during 2026-2034.

The HbA1c testing market is poised for significant growth, driven by the rising prevalence of diabetes and the increasing emphasis on preventive healthcare. As healthcare providers focus on early diagnosis and management of diabetes, HbA1c testing has emerged as a critical tool for monitoring long-term glucose control. This test not only aids in the diagnosis of diabetes but also plays a vital role in assessing the effectiveness of treatment regimens, making it indispensable in diabetes care.

Technological advancements in diagnostic testing are reshaping the HbA1c testing landscape. Innovations in point-of-care testing devices are enhancing accessibility and convenience, allowing patients to monitor their glucose levels more effectively. These devices provide rapid results, enabling timely interventions and personalized treatment plans. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols, thereby improving overall health outcomes.

The growing awareness of the importance of diabetes management is also driving market expansion. Public health initiatives aimed at educating individuals about the risks associated with uncontrolled diabetes are prompting more people to seek regular testing. As healthcare systems increasingly prioritize value-based care, the demand for reliable and accurate HbA1c testing solutions is expected to rise. In this evolving environment, stakeholders are well-positioned to capitalize on the growth potential of the HbA1c testing market, driving innovation and improving patient care in the process.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents
• Kits

By Technology

• Ion-exchange HPLC
• Enzymatic assay
• Affinity binding chromatography
• Turbidimetric inhibition immunoassay
• Others

By End User

• Hospitals and clinics
• Diagnostic laboratories
• Homecare
• Research institution
• Others

COMPANIES PROFILED

• Abbott, BioRad Laboratories, Inc, ARKRAY, Inc, Danaher, F HoffmannLa Roche Ltd, Siemens Healthcare GmbH, TransAsia BioMedicals, Trinity Biotech Ireland, EKF Diagnostics, Randox Laboratories Ltd, HemoCue India, Eurolyser Diagnostica GmbH, Sekisui Diagnostics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HBA1C TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Units)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL HBA1C TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN and Units)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Ion-exchange HPLC Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.3. Enzymatic assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.4. Affinity binding chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.5. Turbidimetric inhibition immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL HBA1C TESTING MARKET: BY END USER 2022-2034 (USD MN and Units)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.3. Diagnostic laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.5. Research institution Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL HBA1C TESTING MARKET: BY REGION 2022-2034(USD MN and Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HBA1C TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Bio-Rad LaboratoriesInc
  • 9.2.3 ARKRAYInc
  • 9.2.4 Danaher
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 Siemens Healthcare GmbH
  • 9.2.7 TransAsia Bio-Medicals
  • 9.2.8 Trinity Biotech Ireland
  • 9.2.9 EKF Diagnostics
  • 9.2.10 Randox Laboratories Ltd
  • 9.2.11 HemoCue India
  • 9.2.12 Eurolyser Diagnostica GmbH
  • 9.2.13 Sekisui Diagnostics